Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Loop ileostomy-mediated fecal stream diversion is associated with microbial dysbiosis.

Beamish EL, Johnson J, Shaw EJ, Scott NA, Bhowmick A, Rigby RJ.

Gut Microbes. 2017 Sep 3;8(5):467-478. doi: 10.1080/19490976.2017.1339003. Epub 2017 Jun 16.

2.

Intestinal epithelial suppressor of cytokine signaling 3 (SOCS3) impacts on mucosal homeostasis in a model of chronic inflammation.

Shaw EJ, Smith EE, Whittingham-Dowd J, Hodges MD, Else KJ, Rigby RJ.

Immun Inflamm Dis. 2017 Sep;5(3):336-345. doi: 10.1002/iid3.171. Epub 2017 May 15.

3.

Plexin B2 and Semaphorin 4C Guide T Cell Recruitment and Function in the Germinal Center.

Yan H, Wu L, Shih C, Hou S, Shi J, Mao T, Chen W, Melvin B, Rigby RJ, Chen Y, Jiang H, Friedel RH, Vinuesa CG, Qi H.

Cell Rep. 2017 May 2;19(5):995-1007. doi: 10.1016/j.celrep.2017.04.022.

4.

Intestinal bacteria are necessary for doxorubicin-induced intestinal damage but not for doxorubicin-induced apoptosis.

Rigby RJ, Carr J, Orgel K, King SL, Lund PK, Dekaney CM.

Gut Microbes. 2016 Sep 2;7(5):414-23. doi: 10.1080/19490976.2016.1215806. Epub 2016 Jul 26.

5.

Human gut dendritic cells drive aberrant gut-specific t-cell responses in ulcerative colitis, characterized by increased IL-4 production and loss of IL-22 and IFNγ.

Mann ER, Bernardo D, Ng SC, Rigby RJ, Al-Hassi HO, Landy J, Peake ST, Spranger H, English NR, Thomas LV, Stagg AJ, Knight SC, Hart AL.

Inflamm Bowel Dis. 2014 Dec;20(12):2299-307. doi: 10.1097/MIB.0000000000000223.

PMID:
25397892
6.

Intestinal epithelial suppressor of cytokine signaling 3 enhances microbial-induced inflammatory tumor necrosis factor-α, contributing to epithelial barrier dysfunction.

Thagia I, Shaw EJ, Smith E, Else KJ, Rigby RJ.

Am J Physiol Gastrointest Liver Physiol. 2015 Jan 1;308(1):G25-31. doi: 10.1152/ajpgi.00214.2014. Epub 2014 Nov 6.

7.

Cannabinoid-induced autophagy regulates suppressor of cytokine signaling-3 in intestinal epithelium.

Koay LC, Rigby RJ, Wright KL.

Am J Physiol Gastrointest Liver Physiol. 2014 Jul 15;307(2):G140-8. doi: 10.1152/ajpgi.00317.2013. Epub 2014 May 15.

8.

B cell priming for extrafollicular antibody responses requires Bcl-6 expression by T cells.

Lee SK, Rigby RJ, Zotos D, Tsai LM, Kawamoto S, Marshall JL, Ramiscal RR, Chan TD, Gatto D, Brink R, Yu D, Fagarasan S, Tarlinton DM, Cunningham AF, Vinuesa CG.

J Exp Med. 2011 Jul 4;208(7):1377-88. doi: 10.1084/jem.20102065. Epub 2011 Jun 27.

9.

CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation.

Tze LE, Horikawa K, Domaschenz H, Howard DR, Roots CM, Rigby RJ, Way DA, Ohmura-Hoshino M, Ishido S, Andoniou CE, Degli-Esposti MA, Goodnow CC.

J Exp Med. 2011 Jan 17;208(1):149-65. doi: 10.1084/jem.20092203. Epub 2011 Jan 10.

10.

IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses.

Linterman MA, Beaton L, Yu D, Ramiscal RR, Srivastava M, Hogan JJ, Verma NK, Smyth MJ, Rigby RJ, Vinuesa CG.

J Exp Med. 2010 Feb 15;207(2):353-63. doi: 10.1084/jem.20091738. Epub 2010 Feb 8.

11.

Inflammation enhances resection-induced intestinal adaptive growth in IL-10 null mice.

Speck KE, Garrison AP, Rigby RJ, von Allmen DC, Lund PK, Helmrath MA.

J Surg Res. 2011 Jun 1;168(1):62-9. doi: 10.1016/j.jss.2009.09.051. Epub 2009 Oct 22.

12.

Logic and extent of miRNA-mediated control of autoimmune gene expression.

Vinuesa CG, Rigby RJ, Yu D.

Int Rev Immunol. 2009;28(3-4):112-38. doi: 10.1080/08830180902934909. Review.

PMID:
19811318
13.

A new animal model of postsurgical bowel inflammation and fibrosis: the effect of commensal microflora.

Rigby RJ, Hunt MR, Scull BP, Simmons JG, Speck KE, Helmrath MA, Lund PK.

Gut. 2009 Aug;58(8):1104-12. doi: 10.1136/gut.2008.157636. Epub 2009 Apr 26.

14.

Follicular helper T cells are required for systemic autoimmunity.

Linterman MA, Rigby RJ, Wong RK, Yu D, Brink R, Cannons JL, Schwartzberg PL, Cook MC, Walters GD, Vinuesa CG.

J Exp Med. 2009 Mar 16;206(3):561-76. doi: 10.1084/jem.20081886. Epub 2009 Feb 16.

15.

Roquin differentiates the specialized functions of duplicated T cell costimulatory receptor genes CD28 and ICOS.

Linterman MA, Rigby RJ, Wong R, Silva D, Withers D, Anderson G, Verma NK, Brink R, Hutloff A, Goodnow CC, Vinuesa CG.

Immunity. 2009 Feb 20;30(2):228-41. doi: 10.1016/j.immuni.2008.12.015. Epub 2009 Feb 12.

16.

What are the mechanisms of fibrosis in IBD?

Lund PK, Rigby RJ.

Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S127-8. doi: 10.1002/ibd.20681. No abstract available. Erratum in: Inflamm Bowel Dis. 2009 Sep;15(9):1438-47.

PMID:
18816738
17.

SiLEncing SLE: the power and promise of small noncoding RNAs.

Rigby RJ, Vinuesa CG.

Curr Opin Rheumatol. 2008 Sep;20(5):526-31. doi: 10.1097/BOR.0b013e328304b45e. Review.

PMID:
18698172
18.

Bacterial-dependent up-regulation of intestinal bile acid binding protein and transport is FXR-mediated following ileo-cecal resection.

Dekaney CM, von Allmen DC, Garrison AP, Rigby RJ, Lund PK, Henning SJ, Helmrath MA.

Surgery. 2008 Aug;144(2):174-81. doi: 10.1016/j.surg.2008.03.035.

19.

Expansion of intestinal stem cells associated with long-term adaptation following ileocecal resection in mice.

Dekaney CM, Fong JJ, Rigby RJ, Lund PK, Henning SJ, Helmrath MA.

Am J Physiol Gastrointest Liver Physiol. 2007 Nov;293(5):G1013-22. Epub 2007 Sep 13.

20.

Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon.

Rigby RJ, Simmons JG, Greenhalgh CJ, Alexander WS, Lund PK.

Oncogene. 2007 Jul 19;26(33):4833-41. Epub 2007 Feb 12.

PMID:
17297444
21.

Identification of chromosome intervals from 129 and C57BL/6 mouse strains linked to the development of systemic lupus erythematosus.

Heidari Y, Bygrave AE, Rigby RJ, Rose KL, Walport MJ, Cook HT, Vyse TJ, Botto M.

Genes Immun. 2006 Oct;7(7):592-9. Epub 2006 Aug 31.

PMID:
16943797
22.

SOC-ing it to tumors: suppressors of cytokine signaling as tumor repressors.

Lund PK, Rigby RJ.

Gastroenterology. 2006 Jul;131(1):317-9. No abstract available.

PMID:
16831614
23.

Mice, humans and haplotypes--the hunt for disease genes in SLE.

Rigby RJ, Fernando MM, Vyse TJ.

Rheumatology (Oxford). 2006 Sep;45(9):1062-7. Epub 2006 Jun 12. Review.

PMID:
16769771
24.

Characteristics of intestinal dendritic cells in inflammatory bowel diseases.

Hart AL, Al-Hassi HO, Rigby RJ, Bell SJ, Emmanuel AV, Knight SC, Kamm MA, Stagg AJ.

Gastroenterology. 2005 Jul;129(1):50-65.

PMID:
16012934
25.

Production of interleukin (IL)-10 and IL-12 by murine colonic dendritic cells in response to microbial stimuli.

Rigby RJ, Knight SC, Kamm MA, Stagg AJ.

Clin Exp Immunol. 2005 Feb;139(2):245-56.

26.

Multiple loci are linked with anti-red blood cell antibody production in NZB mice -- comparison with other phenotypes implies complex modes of action.

Lee NJ, Rigby RJ, Gill H, Boyle JJ, Fossati-Jimack L, Morley BJ, Vyse TJ.

Clin Exp Immunol. 2004 Oct;138(1):39-46.

27.

Spontaneous autoimmunity in 129 and C57BL/6 mice-implications for autoimmunity described in gene-targeted mice.

Bygrave AE, Rose KL, Cortes-Hernandez J, Warren J, Rigby RJ, Cook HT, Walport MJ, Vyse TJ, Botto M.

PLoS Biol. 2004 Aug;2(8):E243. Epub 2004 Aug 17.

28.

A novel locus regulates both retroviral glycoprotein 70 and anti-glycoprotein 70 antibody production in New Zealand mice when crossed with BALB/c.

Rigby RJ, Rozzo SJ, Gill H, Fernandez-Hart T, Morley BJ, Izui S, Kotzin BL, Vyse TJ.

J Immunol. 2004 Apr 15;172(8):5078-85.

29.
30.

Safety and efficacy of simvastatin in hypercholesterolemic patients undergoing chronic renal dialysis.

Saltissi D, Morgan C, Rigby RJ, Westhuyzen J.

Am J Kidney Dis. 2002 Feb;39(2):283-90.

PMID:
11840368
31.

A retrospective analysis of mycophenolic acid and cyclosporin concentrations with acute rejection in renal transplant recipients.

Pillans PI, Rigby RJ, Kubler P, Willis C, Salm P, Tett SE, Taylor PJ.

Clin Biochem. 2001 Feb;34(1):77-81.

PMID:
11239520
32.

Is obesity a favorable prognostic factor in peritoneal dialysis patients?

Johnson DW, Herzig KA, Purdie DM, Chang W, Brown AM, Rigby RJ, Campbell SB, Nicol DL, Hawley CM.

Perit Dial Int. 2000 Nov-Dec;20(6):715-21.

PMID:
11216565
33.

A comparison of the effects of dialysis and renal transplantation on the survival of older uremic patients.

Johnson DW, Herzig K, Purdie D, Brown AM, Rigby RJ, Nicol DL, Hawley CM.

Transplantation. 2000 Mar 15;69(5):794-9.

PMID:
10755528
34.

Novel surveillance and cure of a donor-transmitted lymphoma in a renal allograft recipient.

Herzig KA, Falk MC, Jonsson JR, Axelsen RA, Griffin AD, Hawley CM, Rigby RJ, Cobcroft R, Nicol DL, Powell EE, Johnson DW.

Transplantation. 2000 Jul 15;70(1):149-52.

PMID:
10919592
35.

The kinetics of mycophenolic acid and its glucuronide metabolite in adult kidney transplant recipients.

Johnson AG, Rigby RJ, Taylor PJ, Jones CE, Allen J, Franzen K, Falk MC, Nicol D.

Clin Pharmacol Ther. 1999 Nov;66(5):492-500.

PMID:
10579476
36.

Serum leptin correlates with fat mass but not dietary energy intake in continuous ambulatory peritoneal dialysis patients.

Parry RG, Johnson DW, Carey DG, Hibbins M, Chang W, Purdie D, Rigby RJ.

Perit Dial Int. 1998 Nov-Dec;18(6):569-75.

PMID:
9932654
37.

Proteolipid in peritoneal effluent of CAPD patients.

Mizusawa Y, Thomas K, Hills BA, Burke JR, Mizushima W, Rigby RJ, Crawford C, Freeman J.

Perit Dial Int. 1998 Mar-Apr;18(2):225-8. No abstract available.

PMID:
9576373
38.

Sclerosing peritonitis: the experience in Australia.

Rigby RJ, Hawley CM.

Nephrol Dial Transplant. 1998 Jan;13(1):154-9.

PMID:
9481732
39.

A randomized trial comparing 1.25 mmol/l calcium dialysate to 1.75 mmol/l calcium dialysate in CAPD patients.

Johnson DW, Rigby RJ, McIntyre HD, Brown A, Freeman J.

Nephrol Dial Transplant. 1996 Jan;11(1):88-93.

PMID:
8649658
40.

The role of DEXA bone densitometry in evaluating renal osteodystrophy in continuous ambulatory peritoneal dialysis patients.

Johnson DW, McIntyre HD, Brown A, Freeman J, Rigby RJ.

Perit Dial Int. 1996 Jan-Feb;16(1):34-40.

PMID:
8616170
41.

Recovery of gastrointestinal function after renal transplantation in a patient with sclerosing peritonitis secondary to continuous ambulatory peritoneal dialysis.

Hawley CM, Wall DR, Johnson DW, Campbell SB, Griffin AD, Rigby RJ, Petrie JJ.

Am J Kidney Dis. 1995 Oct;26(4):658-61.

PMID:
7573023
42.

Effect of OKT3 in steroid-resistant renal transplant rejection.

Petrie JJ, Rigby RJ, Hawley CM, Suranyi MG, Whitby M, Wall D, Hardie IR.

Transplantation. 1995 Feb 15;59(3):347-52.

PMID:
7871563
44.

First report of an Australian randomised trial comparing cyclosporine+prednisolone with cyclosporine+azathioprine and cyclosporine+azathioprine+prednisolone in renal transplantation.

Hardie IR, Tiller DJ, Mahony JF, Miach PJ, Thomson NM, Thatcher GN, Rigby RJ, Menzies BL.

Transplant Proc. 1992 Oct;24(5):2241-2. No abstract available.

PMID:
1413040
45.

Onset of dialysis encephalopathy in cyclosporine-treated renal allograft recipients.

Hawley CM, Rigby RJ, Boyle RS, Petrie JJ.

Am J Kidney Dis. 1990 Apr;15(4):364-8.

PMID:
2321647
46.

Cyclosporin A in the treatment of childhood glomerulonephritis.

James RW, Burke JR, Petrie JJ, Rigby RJ, Williams M.

Aust N Z J Med. 1989 Jun;19(3):198-201.

PMID:
2775040
47.

The ketoconazole-cyclosporin interaction in an elderly renal transplant patient.

Charles BG, Ravenscroft PJ, Rigby RJ.

Aust N Z J Med. 1989 Jun;19(3):292-3.

PMID:
2673179
48.

Selection of ESRD treatment: an international study.

Mattern WD, McGaghie WC, Rigby RJ, Nissenson AR, Dunham CB, Khayrallah MA.

Am J Kidney Dis. 1989 Jun;13(6):457-64.

PMID:
2658559
49.

Monitoring the response to anti-rejection therapy with serum neopterin.

Smillie AE, Rigby RJ, Petrie JJ.

Transplant Proc. 1989 Feb;21(1 Pt 2):1869-70. No abstract available.

PMID:
2652608
50.

A comparison of triple therapy with double therapy (cyclosporine/azathioprine) in low-risk, first cadaveric renal allograft recipients.

Restifo AC, Petrie JJ, Rigby RJ, Hardie IR, Jacob CK, Russ GR, Mathew TH.

Transplant Proc. 1989 Feb;21(1 Pt 2):1604-5. No abstract available.

PMID:
2652522

Supplemental Content

Loading ...
Support Center